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Two apoprotein A-I (apoA-I)-containing lipoproteins, one containing apoA-I and apoA-II (LpA-I/A-II) and the other containing only apoA-I 
(LpA-I), were examined for their effect on CuZ+- mediated oxidation of low density lipoprotein (LDL). The presence of LpA-I or LpA-I/A-II pre- 
vented LDL oxidation when assessed by the electrophoretic mobility, apoprotein B fragmentation and amounts of thiobarbituric acid-reactive sub- 
stances, The protection of LDL oxidation by these lipoproteins was effective for up to 6 h, with LpA-I being more active than LpA-I/A-II. Results 
from these in vitro model experiments raise a possibility that LpA-I may play a role in protecting LDL from Ct?+-mediated oxidation. 
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1. INTRODUCTION 
ApoA-I-containing lipoproteins isolated by im- 
munological methods most probably reflect a more 
native state than conventionally available HDL because 
ultracentrifugation steps are not involved in the isola- 
tion procedures [1,2]. We isolated and characterized 
two different species of apoA-I-containing lipopro- 
teins: lipoprotein containing apoA-I and apoA-II 
(LpA-I/A-II) and lipoprotein containing apoA-I but no 
apoA-II (LpA-I) [3-51. Age- and sex-related changes in 
LpA-I were higher in females than in males, both dur- 
ing and after puberty, whereas LpA-I/A-II levels re- 
mained constant. Thus, we suggested that the sex 
difference in the incidence of coronary heart disease [5] 
is accounted for by the change in LpA-I levels. 
However, less is known about the functional difference 
of these lipoproteins at a molecular level. The protec- 
tive role of HDL in atherosclerosis is generally at- 
tributed to acceleration of cholesterol efflux from 
cholesteryl ester-laden cells (foam cells), whereas no in- 
formation is available on its direct role in intracellular 
accumulation of cholesteryl esters. The scavenger 
receptor for chemically modified LDL has been pro- 
posed as a potential mechanism for foam cell forma- 
tion [6-91. Recent studies focus on the identification of 
a natural ligand for this receptor, and an oxidative pro- 
cess which occurs in vivo to LDL is proposed as a ma- 
jor potential candidate [lo-141. As a first step to 
understand the role of HDL in the atherogenic process, 
we examined the effect of HDL and apoA-I-containing 
lipoproteins on Cu2+ -mediated oxidation of LDL in 
vitro. 
2. MATERIALS AND METHODS 
2.1. Preparation of lipoproteins 
LDL (d = 1.019-1.063) and HDL (d = 1.063-l .21) were isolated 
from human plasma by conventional ultracentrifugation [15]. Two 
species of apoA-I-containing lipoprotein were prepared by the com- 
bination of anti-apoA-I and anti-apoA-II immunosorbent columns as 
described previously [3-51. Briefly, fresh human plasma was applied 
to an anti-apoA-I immunosorbent column. After washing with 
0.01 M Tris-HCl, pH 7YO.5 M NaCl/l mM EDTA (buffer A), the 
column was eluted with 0.1 M acetic acid/l mM EDTA (pH 3.0). 
Each effluent was immediately adjusted to pH 7.4 with 1 M Tris solu- 
tion, followed by dialysis against 0.15 M NaCl/l mM EDTA (pH 
7.4). The lipoprotein fraction containing apoA-I was then concen- 
trated and applied to an anti-apoA-II immunosorbent column to 
isolate LpA-I and LpA-I/A-II. The column was washed with buffer 
A to obtain the unbound fraction (LpA-I). The bound fraction cor- 
responding to LpA-I/A-II was eluted with 0.1 M acetic acid/l mM 
EDTA (pH 3.0). To examine the effect on Cu”-mediated LDL ox- 
idation, LpA-I and LpA-I/A-II were dialyzed against PBS to remove 
EDTA. 
2.2. Oxidation of LDL by Cu2+ 
Correspondence address: T. Ohta, Department of Pediatrics, 
Kumamoto University Medical School, Kumamoto 860, Japan 
Abbreviations: LpA-I, lipoprotein containing apoprotein A-I with no 
apoprotein A-II; LpA-I/A-II, lipoprotein containing apoprotein A-I 
and A-II; HDL, high density lipoprotein; LDL, low density lipopro- 
tein; PBS, phosphate-buffered saline; TBARS, thiobarbituric acid 
reactive substances 
LDL was oxidized as described [16]. Briefly, 0.1 mg of LDL was 
incubated at 37°C in 1.0 ml of EDTA-free PBS with 5 pM CuS04 in 
the presence or absence of LpA-I, LpA-I/A-II, HDL or human 
serum albumin (HSA). Control incubations were done in the presence 
of 0.2 mM EDTA but no CuSO4. Oxidation was terminated by 
refrigeration and the addition of 0.2 mM EDTA and 40/M 
butylated hydroxytoluene. Incubation periods were varied between 3 
and 12 h. 
2.3. Analytical procedures 
Agarose gel electrophoresis of lipoproteins was performed using a 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
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Fig. 1. Effect of LpA-I and LpA-I/A-II on Cu’+-mediated oxidation 
of LDL. LDL (0.1 mg) was incubated, in a final volume of 1 .O ml of 
PBS, with 5 pM CuSO4 at 37°C for 3 h in the absence (B) or presence 
of 150pg/mI of HDL (C), LpA-I/A-II (D), or LpA-I (E). As a 
control, LDL was incubated in parallel without CuSO4 (A). Each 
sample was run on agarose gel electrophoresis. Arrows show the 
origin of electrophoresis. 
Pol-E film system (Corning) at pH 8.6, followed by staining with Fat 
Red 7B. Sodium dodecyl sulfate gradient gel electrophoresis (4-30%) 
was performed as described [3-S] and stained by Coomassie brilliant 
blue R-250. Protein was measured as described in [17]. In this study, 
lipoprotein (LDL, HDL, LpA-I/A-II and LpA-I) concentrations 
were expressed in mg protein/ml. Lipid peroxidation was estimated 
as the fluorescent reaction with thiobarbituric acid using freshly 
diluted tetramethoxypropane as a standard [18]. 
3. RESULTS 
LDL (1OOpg) was mixed with 150~g/ml of LpA- 
I/A-II, LpA-I or HDL in a total volume of 1.0 ml of 
Concentration of effector (pg/ml) 
PBS. The oxidation was initiated by the addition of 
10~1 of 0.5 mM CuSO4, followed by incubation at 
37°C for 3 h. Upon agarose gel electrophoresis (fig. l), 
LDL increased its electrophoretic mobility by oxidation 
with Cu2+ (lane B). Under the conditions, the presence 
of LpA-I (lane E), LpA-I/A-II (lane D) or HDL (lane 
C) significantly prevented the increase in the elec- 
trophoretic mobility of LDL, suggesting the protective 
effect of these lipoproteins on LDL oxidation by 
CuSO4. We extended the incubation time from 3 to 
12 h. The results obtained were almost identical or 
similar for up to 6 h-incubation, whereas these protec- 
tive effects of LpA-I/A-II, LpA-I or HDL were no 
longer observed after 12 h-incubation (data not 
shown). Therefore, the following data represent hose 
obtained by 3 h-incubation. 
In our next attempt, the same oxidation reaction was 
performed in the presence of LpA-I/A-II, LpA-I, 
HDL, or HSA at three different concentrations (30, 
100 and 200 pg/ml). Extents of LDL oxidation were 
then assessed both by the increase in the electrophoretic 
mobility and the change in TBARS levels. As shown in 
fig.2, the increase in electrophoretic mobility was 
prevented by the presence of LpA-I/A-II, or LpA-I or 
HSA in a dose-dependent manner (from 30 to 
200 pg/ml, P < 0.005). LpA-I was more effective than 
LpA-I/A-II at the concentration of 200pg/ml, but 
similar to HSA. Although a protective effect reached a 
maximum level at 100 pg/ml, HDL itself was also pro- 
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Fig.2. Dose-dependent effects of ApoA-I-containing lipoproteins on LDL oxidation. Each reaction mixture contained, in a 1 .O ml of PBS, 5 pM 
CuSO4 and three different concentrations of LpA-I (o), LpA-I/A-II (0), HDL (B), HSA (A) and control LDL with no effector (0). After 
incubation at 37°C for 3 h, a portion of each sample was run on agarose gel electrophoresis and stained. The increase in electrophoretic mobility 
of each LDL sample was expressed as relative ratio to that of unmodified LDL (A). Another portion of the sample was determined for TBARS 
levels as described in section 2 (B). Each value was the mean of triplicate experiments and bars show the range. 
436 
Volume 251, number 2 FEBS LETTERS November 1989 
tective. Similar to these effects on the electrophoretic 
mobility, LpA-I/A-II, LpA-I and HSA decreased ose- 
dependently TBARS levels to a similar extent (from 30 
to 200 pug/ml, P < 0.05). The presence of HDL did not 
decrease TBARS levels, and when effects of HDL at 
lOOpg/ml were compared with those at 2OOpg/ml, 
amounts of TBARS appeared to increase. But no 
statistical significance was observed. 
The fragmentation of apoprotein B is known to oc- 
cur to Cu2+-mediated oxidation of LDL [16]. Our LDL 
contained apoB-100, apoB-48 and a few subspecies 
(lane B), but all protein bands disappeared after oxida- 
tion by Cu2+ (lane C). LpA-I contained unknown pro- 
tein of 54 kDa which is now under investigation. 
Therefore, the protein band (54 kDa) seen in lane E 
was not the fragment of apoB. As shown in fig.3, 
apoprotein B fragmentation (lane C) was virtually 
prevented by the presence of LpA-I/A-II (lane D), 
LpA-I (lane E) or HDL (lane F). It was also noted that 
apoA-I of these three lipoproteins seemed intact during 
oxidation, suggesting that apoA-I itself was resistant o 
Cu2+-mediated oxidation. 
4. DISCUSSION 
In the present study, we showed the protective effect 
of LpA-I, LpA-I/A-II and HDL on Cu2+ catalyzed ox- 
ABCDE F 
Fig.3. Effect of ApoA-I-containing lipoproteins on apoprotein B 
fragmentation. LDL (0.1 mg) was incubated for 3 h at 37°C in 
1.0 ml of PBS with 5 PM CuSO4 in the absence (C) or presence of 
150 pg/ml of LpA-I/A-II (D), LpA-I (E), or HDL (F). Each sample 
was run on sodium dodecyl sulfate gradient gel electrophoresis. (A) 
Molecular weight standards in ascending order are 14400, 20100, 
30000, 43000, 67000 and 94000. (B) Native LDL. 
idation of human LDL. As shown in fig.2, the protec- 
tive effect was not specific for these lipoproteins; HSA 
also could prevent Cu2+ -mediated oxidation of LDL. 
Therefore, it seems unlikely that apoA-I-containing 
lipoproteins might play an exclusive role in preventing 
LDL oxidation under normal conditions. However, 
under pathological conditions such as the 
atherosclerotic process where the generation of reactive 
oxygen molecules is increased [19], these lipoproteins 
could play some role in preventing LDL oxidation. 
Hinsberg et al. [20] reported the function of HDL as 
an anti-oxidant. When determined by an elec- 
trophoretic mobility of modified LDL preparations, 
HDL effectively prevented LDL from modification by 
endothelial cells, but had only a partial effect on 
Cu’+-mediated LDL oxidation, whereas in both cases 
TBARS levels were not altered upon addition of HDL. 
Although they did not test the effect of subspecies of 
HDL on LDL oxidation, these data were consistent 
with our present data; the increase in the elec- 
trophoretic mobility of Cu’+-mediated LDL was slight- 
ly prevented by HDL while TBARS levels were not 
affected at all under the same conditions (figs 1 and 2). 
It is of interest that the effects of HDL and affinity 
purified lipoproteins on the oxidation of LDL differed, 
particularly in terms of the amount of TBARS. In our 
preliminary study, HDL was found to consist of LpA- 
I/A-II (60-65%) and LpA-I (35-40%), suggesting that 
200 pug of HDL comprised approx. 125 pg of LpA-I/A- 
II and 75 pg of LpA-I. At this concentration range of 
these apoA-I-containing lipoproteins (75-125 pg/ml), 
TBARS levels of HDL were much higher than those of 
LpA-I and LpA-I/A-II (see fig.2). Thus, it seems likely 
that the lipid composition of HDL might be altered 
during ultracentrifugation steps to be more susceptible 
than the affinity purified lipoprotein to Cu2+-induced 
lipid peroxidation. 
According to the current concept of LDL oxidation, 
chemically active aldehydes such as malondialdehyde 
or 4-hydroxynonenal generated by lipid peroxidation 
from polyunsaturated fatty acids of LDL 
phospholipids might selectively modify lysine residues 
of LDL apoprotein B, thus increasing a net negative 
charge of LDL [21,22]. We observed the different ef- 
fects of LpA-I/A-II and LpA-I on the oxidation of 
LDL. Since LpA-I/A-II and LpA-I generated the 
similar amount of malondialdehyde (see fig.2B), LpA-I 
might act by preventing apoprotein B from its interac- 
tion with malondialdehyde more effectively than LpA- 
I/A-II. However, since we did not measure 
4-hydroxynonenal, it would also be possible that the 
presence of LpA-I/A-II may increase the concentration 
of 4-hydroxynonenal more so than does LpA-I. 
With respect o a functional difference between LpA- 
I/A-II and LpA-I, Barbaras et al. [23] reported that on- 
ly LpA-I was active in promoting cholesterol efflux 
from fat cells. However, in our preliminary ex- 
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periments with cholesteryl ester-laden rat peritoneal 
macrophages which were induced by acetylated LDL, 
cholesterol efflux from these cells was effectively 
enhanced either by LpA-I/A-II or by LpA-I to a similar 
extent. The reason for the discrepancy between their 
data and ours is not clear. The property of these 
lipoproteins could differ. They first isolated HDL by 
conventional ultracentrifugation and used affinity 
chromatographies to prepare LpA-I and LpA-I/A-II, 
while LpA-I/A-II and LpA-I used in the present study 
were isolated directly from the plasma. Differences in 
the cells used for the efflux assay (fat cells versus 
macrophages) may also contribute in part to the 
discrepancy. 
From age- and sex-related changes in LpA-I and the 
constancy of LpA-I/A-II levels, we proposed that 
LpA-I might be responsible for the sex difference in the 
incidence of coronary heart disease [3,5]. If the oxida- 
tion of LDL in an extravascular space could be one of 
the initial events in atherogenesis [24,25], the present 
finding that LpA-I is more active than LpA-I/A-II in 
protecting LDL against its in vitro oxidation by Cu2+ 
would be consistent with our contention. Thus, one can 
assume that the anti-oxidant activity of apoA-I- 
containing lipoproteins might account in part for a pro- 
tective role of HDL in atherogenesis. 
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